MCG researcher to lead a study in learning how cancer treatment might improve the quality of life of those living with HHT.
AUGUSTA, Ga. – A cancer drug that helps keep tumors from growing blood vessels may help patients with a rare genetic condition in which malformed vessels increase their risk for bleeding and anemia. Hereditary hemorrhagic telangiectasia, or HHT...